SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009966
Filing Date
2022-05-16
Accepted
2022-05-16 09:10:01
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atai-20220331.htm   iXBRL 10-Q 4669105
2 EX-4.2 atai-ex4_2.htm EX-4.2 277259
3 EX-31.1 atai-ex31_1.htm EX-31.1 17769
4 EX-31.2 atai-ex31_2.htm EX-31.2 19960
5 EX-32.1 atai-ex32_1.htm EX-32.1 11558
6 EX-32.2 atai-ex32_2.htm EX-32.2 11581
7 GRAPHIC img105015185_0.jpg GRAPHIC 87234
  Complete submission text file 0000950170-22-009966.txt   21524243

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atai-20220331_pre.xml EX-101.PRE 860371
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atai-20220331_lab.xml EX-101.LAB 973944
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atai-20220331.xsd EX-101.SCH 143421
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atai-20220331_def.xml EX-101.DEF 668785
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atai-20220331_cal.xml EX-101.CAL 72699
85 EXTRACTED XBRL INSTANCE DOCUMENT atai-20220331_htm.xml XML 5037660
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 22925901
SIC: 2834 Pharmaceutical Preparations